Keyphrases
Cytokeratin
100%
Serum Biomarkers
100%
Carbohydrate Antigen 19-9 (CA19-9)
100%
Patients with Colorectal Cancer
100%
Carcinoembryonic Antigen
85%
CYFRA 21-1
85%
Colorectal Cancer
57%
Tissue Polypeptide Antigen
57%
Healthy Controls
28%
Primary Chemotherapy
28%
Benign Disease
28%
Patient Management
14%
Area under the Curve
14%
Differential Diagnosis
14%
Healthy Individuals
14%
Lung Cancer
14%
Overall Survival
14%
Treatment Monitoring
14%
Therapy Response
14%
Poor Prognosis
14%
Primary Therapy
14%
Response to Therapy
14%
Poor Response
14%
Colorectal Cancer Patients
14%
Benign Colorectal Disease
14%
Gastrointestinal
14%
Medicine and Dentistry
Biological Marker
100%
Cytokeratin
100%
Colorectal Carcinoma
100%
Tumor Antigen
63%
Cytokeratin 19 Fragment
63%
CA 19-9 Antigen
63%
Fetal Antigen
54%
Chemotherapy
18%
Polypeptide
18%
Antigen Specificity
18%
Benign Tumor
18%
Tissue Polypeptide Antigen
18%
Differential Diagnosis
9%
Treatment Response
9%
Lung Cancer
9%
Overall Survival
9%
Colorectal Disease
9%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Biological Marker
100%
Cytokeratin
100%
CA 19-9 Antigen
63%
Cytokeratin 19 Fragment
63%
Tumor Antigen
63%
Fetal Antigen
54%
Chemotherapy
18%
Polypeptide
18%
Tissue Polypeptide Antigen
18%
Disease
18%
Colorectal Disease
9%
Overall Survival
9%
Lung Cancer
9%
Biochemistry, Genetics and Molecular Biology
Tumor Antigen
100%
Cytokeratin
100%
Antigen Specificity
28%
Overall Survival
14%
Keratin 19
14%